Plain-English translation of NCT06920459 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a follow-up study for patients receiving the Zimmer Biomet Total Shoulder Arthroplasty System — a shoulder replacement implant designed to treat conditions like arthritis, fractures, or severe shoulder damage. Researchers will track how well your shoulder works after surgery and watch for any safety concerns over the course of two years. The goal is to confirm that this implant performs well and remains safe for long-term use.
Even after a device is approved and used in patients, manufacturers are required to continue monitoring its real-world performance and safety. This study collects that ongoing information to make sure the implant continues to work as expected and to catch any rare or long-term problems early.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive shoulder replacement surgery with the Zimmer Biomet implant as part of your standard care. You will then be asked to return for follow-up visits over the next two years, during which your doctor will assess your shoulder function, pain levels, and quality of life. You may also have X-rays taken to monitor the implant. Researchers will track how much your shoulder pain and function improve and watch for any adverse events or complications.
AI-generated summary from trial data · Jun 21, 2026 · Not medical advice
Germany
Netherlands